Vertex Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
VRTX Vertex Pharmaceuticals Inc
STAG STAG Industrial Inc
FNWB First Northwest Bancorp
CRUS Cirrus Logic Inc
LLNKF Litelink Technologies Inc
NVDA NVIDIA Corp
BAC Bank of America Corp
FNCB FNCB Bancorp Inc
IGT International Game Technology PLC
EVA Enviva Partners LP
Go

Health Care : Biotechnology | Large Cap Growth
Company profile

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having two copies (homozygous) of the Delta-F508 (F508del) mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO (ivacaftor) is approved for the treatment of CF patients having the G551D mutation or other specified mutations in their CFTR gene. The Company's development programs in the field of CF include Tezacaftor (VX-661), VX-152, VX-440, VX-659, VX-445 and VX-371. VX-152, VX-440, VX-659 and VX-445 are CFTR corrector compounds.

Closing Price
$225.55
Day's Change
-0.57 (-0.25%)
Bid
--
Ask
--
B/A Size
--
Day's High
227.60
Day's Low
224.39
Volume
(Heavy Day)
Volume:
2,242,187

10-day average volume:
1,727,556
2,242,187
  • Prev Close
    226.12
  • Today's Open
    226.59
  • Day's Range
    224.39-227.60
  • Avg Vol (10-day)
    1.7M
  • Last (time)
    4:00p ET 01/15/21
  • Last (size)
    6
  • 52-Wk Range
    197.47 - 306.08
    LowHigh
  • (03/18/20 - 07/07/20)
    14.22%
  • 47.2%
  • Market Cap
    58.7B
  • Shares Outstanding
    260.0M
  • 10.22
  • 22.45x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 93.98
  • (% of float 12/31/20)
    1.30

Latest News

January 15, 2021
5:45 pm ET
Zacks
January 13, 2021
9:42 am ET
Zacks
January 07, 2021
6:01 am ET
BusinessWire
December 28, 2020
5:04 am ET
BusinessWire
December 22, 2020
5:30 am ET
BusinessWire
December 21, 2020
11:30 am ET
BusinessWire
December 05, 2020
12:30 pm ET
Globe Newswire
December 03, 2020
9:00 am ET
PR Newswire
December 01, 2020
12:21 pm ET
Globe Newswire
November 27, 2020
12:00 am ET
BusinessWire
November 12, 2020
1:01 pm ET
BusinessWire
November 05, 2020
1:00 am ET
BusinessWire
November 04, 2020
9:15 am ET
Globe Newswire
October 30, 2020
5:15 pm ET
MarketWatch
October 29, 2020
2:31 pm ET
Accesswire
1:01 pm ET
BusinessWire
October 22, 2020
8:30 am ET
PR Newswire
October 19, 2020
4:01 pm ET
BusinessWire
October 15, 2020
7:31 am ET
MarketWatch
6:36 am ET
MarketWatch
October 14, 2020
5:08 pm ET
MarketWatch
5:07 pm ET
MarketWatch
October 05, 2020
11:34 am ET
MarketWatch
July 21, 2020
7:45 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.